Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Change in Receivables: 2013-2024

Historic Change in Receivables for Wave Life Sciences (WVE) over the last 10 years, with Dec 2024 value amounting to -$19.7 million.

  • Wave Life Sciences' Change in Receivables rose 749.84% to $8.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.0 million, marking a year-over-year increase of 242.86%. This contributed to the annual value of -$19.7 million for FY2024, which is 193.26% down from last year.
  • As of FY2024, Wave Life Sciences' Change in Receivables stood at -$19.7 million, which was down 193.26% from $21.1 million recorded in FY2023.
  • Over the past 5 years, Wave Life Sciences' Change in Receivables peaked at $21.1 million during FY2023, and registered a low of -$30.0 million during FY2021.
  • Its 2-year average for Change in Receivables is $711,000, with a median of $711,000 in 2023.
  • Data for Wave Life Sciences' Change in Receivables shows a maximum YoY plummeted of 193.26% (in 2024) over the last 5 years.
  • Wave Life Sciences' Change in Receivables (Yearly) stood at -$20.0 million in 2020, then crashed by 50.00% to -$30.0 million in 2021, then reached $21.1 million in 2023, then slumped by 193.26% to -$19.7 million in 2024.